Suppr超能文献

早发性帕金森病 MPTP 模型中小狨猴的 REM 睡眠行为障碍。

REM sleep behavior disorder in the marmoset MPTP model of early Parkinson disease.

机构信息

BU CBRN Protection, TNO Defence, Security and Safety, Rijswijk, The Netherlands.

出版信息

Sleep. 2011 Aug 1;34(8):1119-25. doi: 10.5665/SLEEP.1174.

Abstract

STUDY OBJECTIVES

Sleep problems are a common phenomenon in most neurological and psychiatric diseases. In Parkinson disease (PD), for instance, sleep problems may be the most common and burdensome non-motor symptoms in addition to the well-described classical motor symptoms. Since sleep disturbances generally become apparent in the disease before motor symptoms emerge, they may represent early diagnostic tools and a means to investigate early mechanisms in PD onset. The sleep disturbance, REM sleep behavior disorder (RBD), precedes PD in one-third of patients. We therefore investigated sleep changes in marmoset monkeys treated with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine hydrochloride (MPTP), the non-human primate model for idiopathic PD.

DESIGN

Mild parkinsonism was induced in 5 marmoset monkeys (3M/2F) over a 2-week period of subchronic MPTP treatment. Electroencephalograms (EEGs) and electromyograms (EMGs) were recorded weekly. Motor activity and hand-eye coordination were also measured weekly, and any signs of parkinsonism were noted each day. Sleep parameters, motor activity, and performance data before and after MPTP treatment were compared between MPTP-treated marmosets and 4 control marmosets (1M/3F).

RESULTS

MPTP increased the number of sleep epochs with high-amplitude EMG bouts during REM sleep relative to control animals (mean ± SEM percentage of REM 58.2 ± 9.3 vs. 29.6 ± 7.7; P < 0.05). Of all sleep parameters measured, RBD-like measures discriminated best between MPTP-treated and control animals. On the other hand, functional motor behavior, as measured by hand-eye coordination, was not affected by MPTP treatment (correct trials MPTP: 23.40 ± 3.56 vs. control: 36.13 ± 5.88 correct trials; P = 0.32).

CONCLUSIONS

This REM sleep-specific change, in the absence of profound changes in wake motor behaviors, suggests that the MPTP marmoset model of PD could be used for further studies into the mechanisms and treatment of RBD and other sleep disorders in premotor symptom PD.

摘要

研究目的

睡眠问题是大多数神经和精神疾病的常见现象。例如,在帕金森病(PD)中,睡眠问题可能是除了众所周知的经典运动症状之外最常见和最具负担的非运动症状。由于睡眠障碍通常在疾病出现运动症状之前就已经出现,因此它们可能代表早期诊断工具,并可用于研究 PD 发病的早期机制。在三分之一的患者中,睡眠障碍——快速眼动睡眠行为障碍(RBD)——先于 PD 出现。因此,我们研究了接受 1-甲基-4-苯基-1,2,3,6-四氢吡啶盐酸盐(MPTP)治疗的猕猴的睡眠变化,MPTP 是特发性 PD 的非人类灵长类动物模型。

设计

在亚慢性 MPTP 治疗的 2 周期间,诱导 5 只猕猴(3 只雄性/2 只雌性)出现轻度帕金森病。每周记录脑电图(EEG)和肌电图(EMG)。每周还测量运动活动和手眼协调能力,并每天注意帕金森病的任何迹象。将 MPTP 治疗前后的睡眠参数、运动活动和性能数据与 4 只对照猕猴(1 只雄性/3 只雌性)进行比较。

结果

MPTP 增加了 REM 睡眠期间高振幅 EMG 发作的睡眠期数量,与对照动物相比(平均±SEM REM 中的睡眠期百分比为 58.2±9.3%比 29.6±7.7%;P<0.05)。在所测量的所有睡眠参数中,RBD 样措施最能区分 MPTP 治疗组和对照组。另一方面,手眼协调测量的功能性运动行为不受 MPTP 治疗的影响(正确试验 MPTP:23.40±3.56 与对照:36.13±5.88 正确试验;P=0.32)。

结论

这种 REM 睡眠特异性变化,而清醒运动行为没有明显变化,表明 PD 的 MPTP 猕猴模型可用于进一步研究 PD 运动前症状中 RBD 和其他睡眠障碍的机制和治疗方法。

相似文献

1
REM sleep behavior disorder in the marmoset MPTP model of early Parkinson disease.
Sleep. 2011 Aug 1;34(8):1119-25. doi: 10.5665/SLEEP.1174.
2
REM sleep behavior disorder and REM sleep without atonia in Parkinson's disease.
Neurology. 2002 Aug 27;59(4):585-9. doi: 10.1212/wnl.59.4.585.
3
Surface EMG activity during REM sleep in Parkinson's disease correlates with disease severity.
Parkinsonism Relat Disord. 2014 Jul;20(7):766-71. doi: 10.1016/j.parkreldis.2014.04.011. Epub 2014 Apr 18.
5
Quantitative EEG in Parkinson's disease: when REM sleep behavior disorder onset really matters.
J Neural Transm (Vienna). 2024 Sep;131(9):1039-1046. doi: 10.1007/s00702-024-02809-8. Epub 2024 Jul 25.
8
Neuroprotective effects of riluzole in early phase Parkinson's disease on clinically relevant parameters in the marmoset MPTP model.
Neuropharmacology. 2012 Mar;62(4):1700-7. doi: 10.1016/j.neuropharm.2011.11.016. Epub 2011 Dec 8.
9
A preliminary quantitative analysis of REM sleep chin EMG in Parkinson's disease with or without REM sleep behavior disorder.
Sleep Med. 2012 Jun;13(6):707-13. doi: 10.1016/j.sleep.2012.01.003. Epub 2012 Mar 20.

引用本文的文献

2
Butyrate improves abnormal sleep architecture in a Parkinson's disease mouse model via BDNF/TrkB signaling.
NPJ Parkinsons Dis. 2025 Jun 19;11(1):175. doi: 10.1038/s41531-025-01029-5.
4
Early onset of sleep/wake disturbances in a progressive macaque model of Parkinson's disease.
Sci Rep. 2022 Oct 19;12(1):17499. doi: 10.1038/s41598-022-22381-z.
5
Association Between Dopaminergic Medications and the Evolution of REM Sleep Behavior Disorder in Parkinson's Disease.
Front Neurol. 2022 Jun 10;13:880583. doi: 10.3389/fneur.2022.880583. eCollection 2022.
6
Brain states in freely behaving marmosets.
Sleep. 2022 Aug 11;45(8). doi: 10.1093/sleep/zsac106.
7
Modeling Parkinson's Disease: Not Only Rodents?
Front Aging Neurosci. 2021 Aug 6;13:695718. doi: 10.3389/fnagi.2021.695718. eCollection 2021.
8
Motility Profile of Captive-Bred Marmosets Revealed by a Long-Term In-Cage Monitoring System.
Front Syst Neurosci. 2021 Apr 15;15:645308. doi: 10.3389/fnsys.2021.645308. eCollection 2021.
10
Animal Model for Prodromal Parkinson's Disease.
Int J Mol Sci. 2020 Mar 13;21(6):1961. doi: 10.3390/ijms21061961.

本文引用的文献

1
Premotor Parkinson's disease: clinical features and detection strategies.
Mov Disord. 2009;24 Suppl 2:S665-70. doi: 10.1002/mds.22403.
2
Sleep disorders in Parkinson's disease: the contribution of the MPTP non-human primate model.
Exp Neurol. 2009 Oct;219(2):574-82. doi: 10.1016/j.expneurol.2009.07.019. Epub 2009 Jul 25.
3
Two new test methods to quantify motor deficits in a marmoset model for Parkinson's disease.
Behav Brain Res. 2009 Jun 8;200(1):214-9. doi: 10.1016/j.bbr.2009.01.022.
4
Premotor Parkinson disease.
Neurology. 2009 Feb 17;72(7 Suppl):S1. doi: 10.1212/wnl.0b013e318198dace.
5
Can we image premotor Parkinson disease?
Neurology. 2009 Feb 17;72(7 Suppl):S21-6. doi: 10.1212/WNL.0b013e318198df97.
6
Diagnosis and the premotor phase of Parkinson disease.
Neurology. 2009 Feb 17;72(7 Suppl):S12-20. doi: 10.1212/WNL.0b013e318198db11.
7
Biomarkers for the early detection of Parkinson's and Alzheimer's disease.
Neurodegener Dis. 2008;5(3-4):133-6. doi: 10.1159/000113682. Epub 2008 Mar 6.
8
Quantification of tonic and phasic muscle activity in REM sleep behavior disorder.
J Clin Neurophysiol. 2008 Feb;25(1):48-55. doi: 10.1097/WNP.0b013e318162acd7.
9
The role of the substantia nigra pars compacta in regulating sleep patterns in rats.
PLoS One. 2007 Jun 6;2(6):e513. doi: 10.1371/journal.pone.0000513.
10
Interleukin-1beta mediates sleep alteration in rats with rotenone-induced parkinsonism.
Sleep. 2007 Apr;30(4):413-25. doi: 10.1093/sleep/30.4.413.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验